These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Liver sympathetic denervation reverses obesity-induced hepatic steatosis. Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754 [TBL] [Abstract][Full Text] [Related]
26. Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice. Ge F; Zhou S; Hu C; Lobdell H; Berk PD Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G855-66. PubMed ID: 20595619 [TBL] [Abstract][Full Text] [Related]
27. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice. Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178 [TBL] [Abstract][Full Text] [Related]
28. Ursolic Acid Attenuates Hepatic Steatosis, Fibrosis, and Insulin Resistance by Modulating the Circadian Rhythm Pathway in Diet-Induced Obese Mice. Kwon EY; Shin SK; Choi MS Nutrients; 2018 Nov; 10(11):. PubMed ID: 30423963 [TBL] [Abstract][Full Text] [Related]
29. Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. Qin Y; Tian YP Lipids Health Dis; 2010 Jul; 9():78. PubMed ID: 20653983 [TBL] [Abstract][Full Text] [Related]
30. Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin. Ge JF; Walewski JL; Anglade D; Berk PD Semin Liver Dis; 2016 Sep; 36(4):360-372. PubMed ID: 27997977 [TBL] [Abstract][Full Text] [Related]
31. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913 [TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323 [TBL] [Abstract][Full Text] [Related]
33. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling. Yao Y Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448 [TBL] [Abstract][Full Text] [Related]
34. Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity. Kern M; Klöting N; Niessen HG; Thomas L; Stiller D; Mark M; Klein T; Blüher M PLoS One; 2012; 7(6):e38744. PubMed ID: 22761701 [TBL] [Abstract][Full Text] [Related]
35. Trans-Fatty Acids Aggravate Obesity, Insulin Resistance and Hepatic Steatosis in C57BL/6 Mice, Possibly by Suppressing the IRS1 Dependent Pathway. Zhao X; Shen C; Zhu H; Wang C; Liu X; Sun X; Han S; Wang P; Dong Z; Ma X; Hu K; Sun A; Ge J Molecules; 2016 May; 21(6):. PubMed ID: 27248994 [TBL] [Abstract][Full Text] [Related]
36. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867 [TBL] [Abstract][Full Text] [Related]
37. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice. Anhê FF; Varin TV; Le Barz M; Pilon G; Dudonné S; Trottier J; St-Pierre P; Harris CS; Lucas M; Lemire M; Dewailly É; Barbier O; Desjardins Y; Roy D; Marette A Diabetologia; 2018 Apr; 61(4):919-931. PubMed ID: 29270816 [TBL] [Abstract][Full Text] [Related]
38. Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice. Soufi N; Hall AM; Chen Z; Yoshino J; Collier SL; Mathews JC; Brunt EM; Albert CJ; Graham MJ; Ford DA; Finck BN J Biol Chem; 2014 Oct; 289(43):30177-88. PubMed ID: 25213859 [TBL] [Abstract][Full Text] [Related]
39. Effect of TNF-alpha--converting enzyme inhibitor on insulin resistance in fructose-fed rats. Togashi N; Ura N; Higashiura K; Murakami H; Shimamoto K Hypertension; 2002 Feb; 39(2 Pt 2):578-80. PubMed ID: 11882611 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. Derdak Z; Villegas KA; Harb R; Wu AM; Sousa A; Wands JR J Hepatol; 2013 Apr; 58(4):785-91. PubMed ID: 23211317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]